Looks Like This Service Is On Hold
I will design your fda clinical study protocol and endpoint strategy


About this gig
Are you developing a medical device that requires clinical evidence for FDA submission? I provide expert clinical study design and protocol development services tailored to your regulatory pathway.
What You Get:
- SR/NSR (Significant Risk / Non-Significant Risk) determination for your device
- - Complete study design with appropriate control groups and randomization strategy
- - Primary and secondary endpoint selection aligned with FDA guidance documents
- - Patient population definition with inclusion/exclusion criteria
- - Sample size justification using validated biostatistical methods
- - Statistical Analysis Plan (SAP) overview
- - Regulatory timeline mapping for IDE submission readiness
Why Work With Me:
I specialize in FDA medical device clinical study design under 21 CFR 812 (IDE regulations). My protocols are developed to meet CDRH expectations, reducing the risk of clinical holds or deficiency letters. Whether you need a focused feasibility study or a full pivotal trial protocol, I deliver clear, submission-ready documentation.
All deliverables are provided in Wor
Get to know Ben G
FDA regulatory writer and ISO 13485 QMS specialist for medical devices
- FromUnited States
- Member sinceJan 2022
Languages
English, Portuguese
FAQ
What information do you need to get started?
I need your device description, intended use/indications for use, target patient population, and regulatory pathway (510(k), De Novo, PMA, or IDE). If unsure about the pathway, I can help determine it.
Do you handle both SR and NSR device studies?
Yes. I design protocols for both Significant Risk (SR) and Non-Significant Risk (NSR) device studies. SR studies require an IDE application to FDA, while NSR studies need only IRB approval. I'll help determine your device's risk classification.
